TITLE

Highlights

PUB. DATE
September 2014
SOURCE
Clinical Pharmacology & Therapeutics;Sep2014, Vol. 96 Issue 3, p284
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article cites research on clinical pharmacology and therapeutics. A computational approach has shown a molecular program that helps define the process for embryonic stem cell behavior. Researchers have linked Trichomonas vaginalis parasite to prostate cancer by demonstrating that T. vaginalis macrophage migration factor (TvMIF) has tautomerase activity. A study has shown that expression of an EGF-CFC protein family member in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance.
ACCESSION #
97623578

 

Related Articles

  • Stem Cell Science: Current Ethical and Policy Issues. Mauron, A.; Jaconi, M. E. // Clinical Pharmacology & Therapeutics;Sep2007, Vol. 82 Issue 3, p330 

    There is increasing support for embryonic stem (ES) cell research on both sides of the Atlantic. In the United States, the outcome is more funding from non-federal sources, despite the current administration's opposing views. In Europe, a similar pragmatic turn is in the making, but the future...

  • Stem cell culture shock.  // Nature Methods;Mar2005, Vol. 2 Issue 3, p153 

    Relates the author's perspective on the possible use of human embryonic stem cell therapy. Relevance of the incorporation of substantial amount of immunogenic molecule of animal origin in human embryonic stem cell lines in the therapeutic use of human embryonic stem cell; Argumentation of the...

  • Research on embryonic stem cells: The time has come--maybe. Asch-Goodkin, Judith // Contemporary Pediatrics;Jun2005, Vol. 22 Issue 6, p12 

    This article looks at efforts to fund research on embryonic stem cells in the U.S. Embryonic stem cells have enormous therapeutic potential for a wide range of diseases and disabilities but, unhappily, existing techniques for extracting these amazing cells kill the embryo that contains them....

  • The 110th Congress can end debate about embryonic stem cell research. Bartlett, Roscoe // Hill;1/22/2008, Vol. 15 Issue 6, p15 

    The article focuses on the call to end the embryonic stem cell research controversy in the U.S. The author believes that it is not necessary to spend federal taxpayer money to sacrifice the life of human embryos to advance embryonic stem cell research. He stresses that the research violates the...

  • Consent to the use of aborted fetuses in stem cell research and therapies. Pfeffer, N.; Kent, J. // Clinical Ethics;2006, Vol. 1 Issue 4, p216 

    This paper identifies the legal and policy framework relating to the use of aborted fetuses in stem cell research and therapies and contrasts this with the collection of embryos for research. It suggests that more attention should be given to questions about the kind of consent sought by...

  • Stem Cells: Panacea or Pandora's Box? McCaffrey, Ryan M. // Harvard Salient;4/24/2008, p8 

    The article discusses the dispute over the issue of using human embryonic stem (ES) in research. The benefit of ES research is said to be infinite for the improvement of clinical treatments of various medical conditions. Critics of ES cell research argue that it is a degradation of human life...

  • ES research in Australia.  // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Mar2007, Vol. 14 Issue 3, p355 

    The article discusses the outcome and recommendations of a review conducted by Judge Lockhart and an independent committee regarding the effects of embryonic stem cell research on human conception and possible therapies. The review observed that there was not a single view coming from the...

  • UK OKs Hybrid Cells. Houlton, Sarah // Pharmaceutical Executive;Jul2007, Vol. 27 Issue 7, p22 

    The article reports that British government has decided to allow scientists to create human-animal hybrid embryos for stem cell research under the draft of the Human Tissue and Embryos bill, a provision that allows scientists to seek an exception for some research. The bill states that resulting...

  • Infection with Trichomonas vaginalis Increases the Risk of HIV-1 Acquisition. McClelland, R. Scott; SangarĂ©, Laura; Hassan, Wisal M.; Lavreys, Ludo; Mandaliya, Kishorchandra; Kiarie, James; Ndinya-Achola, Jeckoniah; Jaoko, Walter; Baeten, Jared M. // Journal of Infectious Diseases;3/1/2007, Vol. 195 Issue 5, p698 

    We conducted a prospective study among women in Mombasa, Kenya, to determine whether Trichomonas vaginalis infection was associated with an increased risk of human immunodeficiency virus type 1 (HIV-1) infection. At monthly follow-up visits, laboratory screening for HIV-1 and genital tract...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics